| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |